Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Successful tocilizumab treatment in a patient with human herpesvirus 8-positive and human immunodeficiency virus-negative multicentric Castleman's disease of plasma cell type nonresponsive to rituximab-CVP therapy.

Műzes G, Sipos F, Csomor J, Sréter L.

APMIS. 2013 Jul;121(7):668-74. doi: 10.1111/apm.12029. Epub 2012 Nov 20.

PMID:
23163599
[PubMed - indexed for MEDLINE]
2.

HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.

Nicoli P, Familiari U, Bosa M, Allice T, Mete F, Morotti A, Cilloni D, Saglio G, Guerrasio A.

Int J Hematol. 2009 Oct;90(3):392-6. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.

PMID:
19756920
[PubMed - indexed for MEDLINE]
3.

[Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].

Pastor MA, Vasco B, Mosquera JM, Debén G, Bautista P, Requena L.

Actas Dermosifiliogr. 2006 Jul-Aug;97(6):385-90. Review. Spanish.

PMID:
16956518
[PubMed - indexed for MEDLINE]
4.

Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.

Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y.

Am J Pathol. 1997 Dec;151(6):1517-22.

PMID:
9403701
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

How I treat HHV8/KSHV-related diseases in posttransplant patients.

Riva G, Luppi M, Barozzi P, Forghieri F, Potenza L.

Blood. 2012 Nov 15;120(20):4150-9. doi: 10.1182/blood-2012-04-421412. Epub 2012 Sep 11.

PMID:
22968461
[PubMed - indexed for MEDLINE]
Free Article
6.

Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman's disease and related diseases.

Tohda S, Murakami N, Nara N.

Int J Mol Med. 2001 Nov;8(5):549-51.

PMID:
11605026
[PubMed - indexed for MEDLINE]
7.

A case of multicentric Castleman's disease having lung lesion successfully treated with humanized anti-interleukin-6 receptor antibody, tocilizumab.

Higuchi T, Nakanishi T, Takada K, Matsumoto M, Okada M, Horikoshi H, Suzuki K.

J Korean Med Sci. 2010 Sep;25(9):1364-7. doi: 10.3346/jkms.2010.25.9.1364. Epub 2010 Aug 12.

PMID:
20808682
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Castleman's disease: from basic mechanisms to molecular therapeutics.

El-Osta HE, Kurzrock R.

Oncologist. 2011;16(4):497-511. doi: 10.1634/theoncologist.2010-0212. Epub 2011 Mar 25. Review.

PMID:
21441298
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Fifty years of multicentric Castleman's disease.

Waterston A, Bower M.

Acta Oncol. 2004;43(8):698-704. Review.

PMID:
15764213
[PubMed - indexed for MEDLINE]
10.

Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.

Ide M, Kawachi Y, Izumi Y, Kasagi K, Ogino T.

Eur J Haematol. 2006 Feb;76(2):119-23.

PMID:
16405432
[PubMed - indexed for MEDLINE]
11.

Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.

Cervera Grau JM, Galiana Esquerdo G, Llorca Ferrándiz C, Briceño García H, Díaz Castellano M, Férriz Moreno P.

Clin Transl Oncol. 2006 Jul;8(7):540-1.

PMID:
16870545
[PubMed - indexed for MEDLINE]
12.

Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.

van Aalderen MC, Brinkman K, van den Berk GE, Terpstra WE.

Neth J Med. 2010 Feb;68(2):87-90.

PMID:
20167961
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.

Lee JP, Kim DK, Oh DY, Paik JH, Moon KC, Kim S, Kim YS.

Clin Nephrol. 2011 Feb;75(2):165-70.

PMID:
21255547
[PubMed - indexed for MEDLINE]
15.

Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases.

Nagao A, Nakazawa S, Hanabusa H.

J Hematol Oncol. 2014 Jan 17;7(1):10. doi: 10.1186/1756-8722-7-10.

PMID:
24438824
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Multicentric Castleman's disease & HIV infection.

Cotter A, Lambert J, O'Gorman P.

Ir Med J. 2009 Oct;102(9):294-5.

PMID:
19902650
[PubMed - indexed for MEDLINE]
17.

A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.

Gholam D, Vantelon JM, Al-Jijakli A, Bourhis JH.

Ann Hematol. 2003 Dec;82(12):766-8. Epub 2003 Jul 30.

PMID:
12898190
[PubMed - indexed for MEDLINE]
18.

Multicentric Castleman's disease masquerading as HIV-related lymphoma.

Dayyani F, Pantanowitz L, Sandridge TG, Sullivan RJ, Dezube BJ.

Am J Med Sci. 2007 Oct;334(4):317-9.

PMID:
18030193
[PubMed - indexed for MEDLINE]
19.

Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.

Bower M, Newsom-Davis T, Naresh K, Merchant S, Lee B, Gazzard B, Stebbing J, Nelson M.

J Clin Oncol. 2011 Jun 20;29(18):2481-6. doi: 10.1200/JCO.2010.34.1909. Epub 2011 May 9.

PMID:
21555697
[PubMed - indexed for MEDLINE]
Free Article
20.

[Dyspnoea, cough and B symptoms in a 40-year-old woman].

Wolfensberger A, Benz R, Russi EW, Tinguely M, Keller C, Gerber B.

Internist (Berl). 2013 Aug;54(8):1011-5. doi: 10.1007/s00108-013-3327-3. German.

PMID:
23836253
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk